Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Audio Recap

September 29 - October 3, 2021; Virtual
Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Released: December 6, 2021

In this episode, Martin C. Mahoney, MD, PhD, discusses new data on vaccine-preventable diseases from IDWeek 2021, including:

  • Pneumococcal disease
  • Respiratory syncytial virus (RSV)
  • Herpes zoster
  • Influenza

Information on this Educational Activity

Faculty

Martin C. Mahoney, MD, PhD

Professor of Oncology
Department of Internal Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Martin C. Mahoney, MD, PhD, has disclosed that he has received consulting fees from Merck, Pfizer, and Sanofi; fees for non-CME/CE services from GlaxoSmithKline, Merck, Pfizer, and Sanofi; and other financial or material support from Pfizer.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Concise microlearning module featuring expert insight on the cardiorenal benefits of SGLT2 inhibitors in T2D from Clinical Care Options (CCO)

Jennifer B. Green, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: July 12, 2022 Expired: July 11, 2023

Unlocked downloadable slides featuring an overview of the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes, from Clinical Care Options (CCO)

Jennifer B. Green, MD Released: July 12, 2022

Clinical Care Options (CCO) podcast: Drs Karen Costenbader and Brad Rovin discuss health disparities in lupus and lupus nephritis

Karen H. Costenbader, MD, MPH Brad H. Rovin, MD Released: June 2, 2022

On-demand webcast featuring expert discussion of recent advances in systemic lupus erythematosus (SLE) and lupus nephritis, from Clinical Care Options (CCO)

Karen H. Costenbader, MD, MPH Brad H. Rovin, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Released: May 25, 2022 Expired: May 24, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings